Multiple NDM-5-Expressing Escherichia Coli Isolates From an Immunocompromised Pediatric Host
Open Access
- 1 February 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 7 (2), ofaa018
- https://doi.org/10.1093/ofid/ofaa018
Abstract
Background. Genes conferring carbapenem resistance have disseminated worldwide among Gram-negative bacteria. Here we present longitudinal changes in clinically obtained Escherichia coli isolates from 1 immunocompromised pediatric patient. This report demonstrates potential for antibiotic resistance genes and plasmids to emerge over time in clinical isolates from patients receiving intensive anticancer chemotherapy and broad-spectrum antibiotics. Methods. Thirty-three isolates obtained over 7 months from 1 patient were included. Clinical data were abstracted from the medical record. For each isolate, studies included phenotypic antibacterial resistance patterns, sequence typing, bacterial isolate sequencing, plasmid identification, and antibiotic resistance gene identification. Results. Sites of isolation included blood, wound culture, and culture for surveillance purposes from the perianal area. Isolates were of 5 sequence types (STs). All were resistant to multiple classes of antibiotics; 23 (69.6%) were phenotypically resistant to all carbapenems. The bla(NDM-5) gene was identified in 22 (67%) isolates, all of ST-167 and ST-940, and appeared to coincide with the presence of the Inall and IncX3 plasmid. Conclusions. We present unique microbiologic data from 33 multidrug-resistant E. coli isolates obtained over the course of 7 months from an individual patient in the United States. Two E. coli sequence types causing invasive infection in the same patient and harboring the bla(NDM-5) gene, encoded on the IncX3 plasmid and the IncFII plasmid, were identified. This study highlights the emergence of multidrug-resistant bacteria on antibiotic therapy and the necessity of adequate neutrophil number and function in the clearance of bacteremia.This publication has 37 references indexed in Scilit:
- Prevalence and molecular characterisation of New Delhi metallo-β-lactamases NDM-1, NDM-5, NDM-6 and NDM-7 in multidrug-resistant Enterobacteriaceae from IndiaInternational Journal of Antimicrobial Agents, 2014
- First report of blaNDM-1-producing Acinetobacter baumannii isolated in Lebanon from civilians wounded during the Syrian warInternational Journal of Infectious Diseases, 2014
- Worldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative BacteriaBioMed Research International, 2014
- Adaptive and Mutational Resistance: Role of Porins and Efflux Pumps in Drug ResistanceClinical Microbiology Reviews, 2012
- A Novel Variant, NDM-5, of the New Delhi Metallo-β-Lactamase in a Multidrug-Resistant Escherichia coli ST648 Isolate Recovered from a Patient in the United KingdomAntimicrobial Agents and Chemotherapy, 2011
- Long-term carriage of NDM-1-producing Escherichia coliJournal of Antimicrobial Chemotherapy, 2011
- Spread of bla CTX-M-14 Is Driven Mainly by IncK Plasmids Disseminated among Escherichia coli Phylogroups A, B1, and D in SpainAntimicrobial Agents and Chemotherapy, 2009
- Characterization of a New Metallo-beta-Lactamase Gene, bla(NDM-1), and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from IndiaAntimicrobial Agents and Chemotherapy, 2009
- Carbapenemases: the Versatile β-LactamasesClinical Microbiology Reviews, 2007
- The CTX-M β-lactamase pandemicCurrent Opinion in Microbiology, 2006